-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ClBk3e+vXwr0VIJBn9l0y5azGYHRJnbBgAoDb38gncEWgv3DUba8eCjAdt+AL2HT YXCYWxmVP3s+TODl3lpu9g== 0001072613-08-000607.txt : 20080229 0001072613-08-000607.hdr.sgml : 20080229 20080229162551 ACCESSION NUMBER: 0001072613-08-000607 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080226 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20080229 DATE AS OF CHANGE: 20080229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 08656114 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 8-K 1 form8-k_15767.htm FORM 8-K DATED FEBRUARY 26, 2008 Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 

Date of Report (Date of earliest event reported):   February 26, 2008
 
 
 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
                                                                                                                        
 
DELAWARE
1-11083
04-2695240
 (State or other jurisdiction of incorporation)
(Commission file number)
(IRS employer identification no.)
 
 
One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)
 
 
Registrant’s telephone number, including area code: (508) 650-8000

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the fling obligation of the registrant under any of the following provisions:

o   Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

ITEM 5.02.
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On February 26, 2008, the Executive Compensation and Human Resources Committee of our Board of Directors approved a base salary increase and a performance incentive award for James R. Tobin, our Chief Executive Officer.  Mr. Tobin’s base salary for 2008 was increased to $994,000, an increase of $29,000 from his 2007 base salary.  His performance award pursuant to our 2007 Performance Incentive Plan was $710,867, or 75% of his award opportunity, and his performance award opportunity for 2008 has been increased from 100% to 120% of his base salary.

 
 

 
 
 
 
 
 
 
 
 

 
 
 


SIGNATURE


Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
  BOSTON SCIENTIFIC CORPORATION  
     
       
Date:   February 29, 2008
By:
/s/ Lawrence J. Knopf   
    Lawrence J. Knopf   
    Senior Vice President and Deputy General Counsel   
       

 
 
 
 
 
 
 
 
 
 
 
 
 

 


 
 
 

-----END PRIVACY-ENHANCED MESSAGE-----